Redmile Group, LLC - 10%+ Owner at ADC Therapeutics SA

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Stock Symbol
ADCT on NYSE
All Insider Reports
All Insider Reports

Redmile Group, LLC - trading volume in the past year for ADC Therapeutics SA

Holdings reported by Redmile Group, LLC for ADC Therapeutics SA

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares, par value CHF 0.08 per share 15.7M $44M $2.81 Jul 1, 2024 Indirect
Pre-Funded Warrants 8.16M $39.3M $4.81 May 8, 2024 Indirect Common Shares
Common Shares, par value CHF 0.08 per share 13M $36.5M $2.81 Jul 1, 2024 Direct
Pre-Funded Warrants 6.11M $29.4M $4.81 May 8, 2024 Direct Common Shares
Cash-settled Swaps 108K $364K $3.38 Feb 7, 2024 Direct Common Shares
Cash-settled Swaps 11.2K $37.8K $3.38 Feb 2, 2024 Indirect Common Shares

Transactions reported by Redmile Group, LLC for ADC Therapeutics SA

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.